TR201819270T4 - Glikozaminoglikanlar Ve Siklodekstrinlerin Kombinasyonu - Google Patents

Glikozaminoglikanlar Ve Siklodekstrinlerin Kombinasyonu Download PDF

Info

Publication number
TR201819270T4
TR201819270T4 TR2018/19270T TR201819270T TR201819270T4 TR 201819270 T4 TR201819270 T4 TR 201819270T4 TR 2018/19270 T TR2018/19270 T TR 2018/19270T TR 201819270 T TR201819270 T TR 201819270T TR 201819270 T4 TR201819270 T4 TR 201819270T4
Authority
TR
Turkey
Prior art keywords
combination
cyclodextrins
glycosaminoglycans
therapy
treatment
Prior art date
Application number
TR2018/19270T
Other languages
English (en)
Inventor
Pizzoni Angelo
Pizzoni Paolo
Original Assignee
Apharm S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apharm S R L filed Critical Apharm S R L
Publication of TR201819270T4 publication Critical patent/TR201819270T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

Bu buluş, hiyalüronik asit ve kondroitin sülfat olmak üzere iki spesifik glikozaminoglikan ile siklodekstrinlerin enjekte edilebilir bir kombinasyonuyla, ve bu kombinasyonun, iskelet sistemleriyle ilgili hastalıkların tedavisinin, özellikle eklem içi tedavinin yanı sıra deri içi tedavide kullanımı ile ilgilidir.
TR2018/19270T 2013-12-18 2014-12-15 Glikozaminoglikanlar Ve Siklodekstrinlerin Kombinasyonu TR201819270T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002116A ITMI20132116A1 (it) 2013-12-18 2013-12-18 Associazione di glicosamminoglicani e ciclodestrine

Publications (1)

Publication Number Publication Date
TR201819270T4 true TR201819270T4 (tr) 2019-01-21

Family

ID=50115999

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19270T TR201819270T4 (tr) 2013-12-18 2014-12-15 Glikozaminoglikanlar Ve Siklodekstrinlerin Kombinasyonu

Country Status (13)

Country Link
US (1) US9974803B2 (tr)
EP (1) EP3082869B1 (tr)
CN (1) CN105899233B (tr)
BR (1) BR112016013834B1 (tr)
CA (1) CA2932987C (tr)
EA (1) EA032372B1 (tr)
ES (1) ES2707971T3 (tr)
IT (1) ITMI20132116A1 (tr)
MA (1) MA39077A1 (tr)
PT (1) PT3082869T (tr)
TN (1) TN2016000206A1 (tr)
TR (1) TR201819270T4 (tr)
WO (1) WO2015092516A1 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153110A1 (it) * 2015-08-13 2017-02-13 Alfakjn S R L Composizione liquida iniettabile per uso nella terapia infiltrativa intra-articolare
IT201600075246A1 (it) 2016-07-19 2018-01-19 Jointherapeutics S R L Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi.
IT201800010415A1 (it) * 2018-11-19 2020-05-19 Innate S R L Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione.
EP4157290A4 (en) * 2020-06-02 2024-06-05 National University of Singapore COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREFOR

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282717B6 (sk) * 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
FR2811572B1 (fr) 2000-07-17 2003-04-18 Adir Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ES2493840T3 (es) * 2002-10-07 2014-09-12 Zymogenetics, Inc. Procedimiento de administración de FGF-18
US8455458B2 (en) * 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
CN1451369A (zh) * 2003-03-13 2003-10-29 吉林大学 环糊精衍生物在化妆品中的应用
EP1967186B1 (en) * 2005-12-27 2015-03-11 Lion Corporation Composition for soft contact lens and adsorption suppressing method
CN100594029C (zh) * 2006-07-24 2010-03-17 凌沛学 一种关节腔内注射用药物组合物
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
CN101259139A (zh) * 2008-03-13 2008-09-10 北京阜康仁生物制药科技有限公司 一种用于消炎镇痛的药用组合物
US8466278B2 (en) * 2008-09-22 2013-06-18 Arcarios B.V. Carboxyethylated cyclodextrin polysulfates useful as medicaments
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
CH705713B1 (de) * 2012-09-21 2013-05-15 Labo Cosprophar Ag Dermokosmetische Zusammensetzung zur topischen Anwendung.
CN103301118A (zh) * 2013-06-27 2013-09-18 海南卫康制药(潜山)有限公司 注射用精氨酸布洛芬组合物

Also Published As

Publication number Publication date
MA39077A1 (fr) 2017-11-30
TN2016000206A1 (en) 2017-10-06
EP3082869A1 (en) 2016-10-26
CN105899233B (zh) 2020-01-17
BR112016013834B1 (pt) 2022-11-22
CA2932987C (en) 2021-10-12
US20170035799A1 (en) 2017-02-09
US9974803B2 (en) 2018-05-22
EA032372B1 (ru) 2019-05-31
EP3082869B1 (en) 2018-10-31
ES2707971T3 (es) 2019-04-08
PT3082869T (pt) 2019-02-06
BR112016013834A2 (tr) 2017-08-08
EA201691246A1 (ru) 2016-10-31
CA2932987A1 (en) 2015-06-25
WO2015092516A1 (en) 2015-06-25
ITMI20132116A1 (it) 2015-06-19
CN105899233A (zh) 2016-08-24

Similar Documents

Publication Publication Date Title
CY1125443T1 (el) Μη φουκοζυλιωμενα anti-fgfr2iiib αντισωματα
MX355434B (es) Compuesto de pirazin-carboxamida.
CL2015002522A1 (es) Composiciones y métodos para activar "estimulador de interferon gene" - señalización dependientes.
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
BR112015029386A2 (pt) uso de eribulina e lenvatinibe como terapia de combinação para tratamento de câncer
CL2015002710A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso.
MX2016004678A (es) Composiciones para el tratamiento del cancer.
MX390762B (es) Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas
MX378792B (es) Células hospederas modificadas y oligosacáridos híbridos para su uso en producción de bioconjugados.
MX389684B (es) Anticuerpos anti tigit.
CL2016001082A1 (es) Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa
EA201690280A1 (ru) Композиции и способы, относящиеся к выделенным эндофитам
AU350921S (en) Sliding door sill
CY1121515T1 (el) Μεθοδοι και συνθεσεις για την επουλωση πληγων
AU350915S (en) Sliding door sill
MX2015007379A (es) Nuevos compuestos.
MX386055B (es) Uso de medicamentos para disminuir la evolución de la enfermedad de parkinson.
UA116654C2 (uk) Похідні пурину як агоністи канабіноїдного рецептора св2
AU351434S (en) Inverter
MX383944B (es) Composiciones para el cuidado personal.
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
DOP2015000176A (es) Compuestos de azetidiniloxifenilpirrolidina
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
TR201819270T4 (tr) Glikozaminoglikanlar Ve Siklodekstrinlerin Kombinasyonu
MX2016001686A (es) Composicion para el tratamiento contra el envejecimiento de la piel.